Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82601-82650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05583305
Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
N/AEnrolling by invitation
60 participants
Started: Oct 12, 2022 · Completed: Jul 17, 2026
3 conditions1 sponsor1 location
NCT05379946
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors
PHASE1/PHASE2Active, not recruiting
92 participants
Started: Oct 12, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05452213
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
PHASE4Recruiting
1,000 participants
Started: Oct 12, 2022 · Completed: Oct 31, 2026
7 conditions3 sponsors52 locations
NCT05997901
Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study
NARecruiting
40 participants
Started: Oct 12, 2022 · Completed: Sep 12, 2025
2 conditions3 sponsors1 location
NCT05578326
Study of Trilaciclib and Lurbinectidin
PHASE2Recruiting
30 participants
Started: Oct 12, 2022 · Completed: Dec 25, 2027
2 conditions2 sponsors2 locations
NCT05534893
Effect of Blueberries on Immunity and Response to Flu Vaccination
NAActive, not recruiting
52 participants
Started: Oct 12, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05552820
Electroacupuncture for Mild-to-moderate Dry Eye
NARecruiting
168 participants
Started: Oct 12, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT05006287
The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
PHASE2Active, not recruiting
100 participants
Started: Oct 12, 2022 · Completed: May 30, 2024
1 condition1 sponsor1 location
NCT05491525
A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC
PHASE2/PHASE3Recruiting
85 participants
Started: Oct 12, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor6 locations
NCT05553223
Micro-doses of Physical Activity for COPD
NARecruiting
20 participants
Started: Oct 12, 2022 · Completed: Sep 1, 2026
5 conditions1 sponsor1 location
NCT05523167
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
PHASE2/PHASE3Active, not recruiting
265 participants
Started: Oct 12, 2022 · Completed: Feb 1, 2027
6 conditions1 sponsor202 locations
NCT05502237
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
PHASE3Recruiting
1,069 participants
Started: Oct 12, 2022 · Completed: Jun 30, 2028
1 condition2 sponsors227 locations
NCT07176338
Role of Metformin in Posterior Capsule Opacification
NAActive, not recruiting
40 participants
Started: Oct 12, 2022 · Completed: Oct 1, 2025
2 conditions1 sponsor1 location
NCT05739591
Long-term Safety and Efficacy of GBG Study Participants
N/ARecruiting
400 participants
Started: Oct 12, 2022 · Completed: May 19, 2030
1 condition1 sponsor3 locations
NCT04549116
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
PHASE3Active, not recruiting
680 participants
Started: Oct 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor22 locations
NCT05546268
Study of Oral MRT-2359 in Selected Cancer Patients
PHASE1/PHASE2Recruiting
174 participants
Started: Oct 12, 2022 · Completed: Nov 30, 2027
8 conditions1 sponsor22 locations
NCT05419050
Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia
PHASE2Active, not recruiting
15 participants
Started: Oct 12, 2022 · Completed: Jan 9, 2026
1 condition1 sponsor1 location
NCT05541627
A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease
PHASE1/PHASE2Active, not recruiting
5 participants
Started: Oct 12, 2022 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT05517265
Acalabrutinib in Patients With Chronic Lymphocytic Leukemia With Direct Oral Anticoagulation (CICERO)
N/AActive, not recruiting
45 participants
Started: Oct 12, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06166836
a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors
PHASE1/PHASE2Recruiting
140 participants
Started: Oct 12, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors10 locations
NCT05433688
Study on the Performance of Symmcora® Mid-term Suture Versus Novosyn® Suture in Patients Undergoing Robotic Assisted Gastric Bypass Surgery
N/AActive, not recruiting
150 participants
Started: Oct 12, 2022 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05530083
Group Education Helps Smoking Cessation and Hypertension Control
NANot yet recruiting
2,000 participants
Started: Oct 12, 2022 · Completed: Jan 1, 2027
2 conditions1 sponsor0 locations
NCT05267951
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
NARecruiting
9 participants
Started: Oct 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05581680
Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects
NARecruiting
720 participants
Started: Oct 12, 2022 · Completed: Oct 31, 2028
3 conditions1 sponsor1 location
NCT05694650
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
N/ARecruiting
20 participants
Started: Oct 12, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06588569
Multi-mode Ablation and Molecular Imaging Multi-omics Study for Digestive-Origin Malignant Liver Tumors
NAActive, not recruiting
20 participants
Started: Oct 12, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05634356
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
NARecruiting
120 participants
Started: Oct 12, 2022 · Completed: Feb 1, 2025
2 conditions3 sponsors1 location
NCT05388136
Trial Comparing Different Follow-up Strategies
NAActive, not recruiting
550 participants
Started: Oct 12, 2022 · Completed: Oct 11, 2031
1 condition2 sponsors3 locations
NCT05275894
Non-surgical Electrolytic Cleaning Peri-implantitis
NAActive, not recruiting
25 participants
Started: Oct 12, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05625048
Urinary Incontinence After Radical Prostatectomy
NARecruiting
66 participants
Started: Oct 12, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05721859
M-Vizion™ Macroscopic Radiographic Study
N/ARecruiting
70 participants
Started: Oct 12, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor7 locations
NCT05459818
Individual Patient Data Analysis of Viabahn for Peripheral Arterial Disease
N/AActive, not recruiting
1,000 participants
Started: Oct 12, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05297617
Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk
PHASE2Recruiting
696 participants
Started: Oct 12, 2022 · Completed: Nov 30, 2035
1 condition2 sponsors2 locations
NCT05478993
Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With CNS Involvement
PHASE2Recruiting
21 participants
Started: Oct 12, 2022 · Completed: Jul 10, 2025
1 condition2 sponsors2 locations
NCT05420051
Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes
NARecruiting
280 participants
Started: Oct 12, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06573853
Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study
N/ARecruiting
428 participants
Started: Oct 11, 2022 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT05573828
Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function
NARecruiting
394 participants
Started: Oct 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05582902
Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients
N/ARecruiting
60 participants
Started: Oct 11, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors11 locations
NCT05503485
Existential Group Treatment for Older Adults (75+) With Psychological Distress in Primary Care
NARecruiting
140 participants
Started: Oct 11, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors7 locations
NCT05498181
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
PHASE2Recruiting
100 participants
Started: Oct 11, 2022 · Completed: Jul 30, 2026
1 condition2 sponsors1 location
NCT05507125
Regulation of Inflammatory Genes in Hidradenitis Suppurativa
N/ARecruiting
200 participants
Started: Oct 11, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT05572047
Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients with Atrial Fibrillation
NARecruiting
25 participants
Started: Oct 11, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT05567861
Virtual Reality for Fibromyalgia
N/AActive, not recruiting
60 participants
Started: Oct 11, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05444699
Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age
PHASE4Recruiting
210 participants
Started: Oct 11, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor2 locations
NCT05537740
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors
PHASE1Active, not recruiting
129 participants
Started: Oct 11, 2022 · Completed: May 4, 2027
1 condition1 sponsor26 locations
NCT05543681
Clinical Trial on Agitation in Alzheimer's Dementia
PHASE2Recruiting
164 participants
Started: Oct 11, 2022 · Completed: Mar 30, 2026
5 conditions1 sponsor26 locations
NCT05577416
A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma
EARLY_PHASE1Recruiting
15 participants
Started: Oct 11, 2022 · Completed: Dec 1, 2025
1 condition3 sponsors1 location
NCT05254314
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
PHASE2Recruiting
100 participants
Started: Oct 11, 2022 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT05267704
Evaluating the Feasibility of VR for Pediatric Renal Biopsies
NARecruiting
20 participants
Started: Oct 11, 2022 · Completed: Aug 1, 2024
3 conditions1 sponsor1 location
NCT05179499
Early Vasopressors in Sepsis
PHASE3Recruiting
1,005 participants
Started: Oct 11, 2022 · Completed: Oct 31, 2027
1 condition7 sponsors23 locations